Efexor XL licence extended

Efexor XL (venlafaxine) is now indicated in moderate to severe generalised social anxiety disorder/social phobia in adults.

Efexor is also indicated in major depressive disorder and in moderate to severe generalised anxiety disorder. The recommended dose in social anxiety disorder is 75mg once daily.

If the patient has failed to respond after 12 weeks, alternative therapy should be considered. Continuation of treatment in a responding patient can be considered on an individual basis, but there is no evidence of efficacy beyond six months.

 

Further information: Wyeth 0845 3670098

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Free coronavirus news and resources on MIMS, MIMS Learning and GPonline

Free coronavirus news and resources on MIMS, MIMS Learning and GPonline

As the coronavirus crisis continues, we at Haymarket...

Live updates: Coronavirus (COVID-19) in the UK

Live updates: Coronavirus (COVID-19) in the UK

Use our timeline to follow the latest coronavirus developments...

Transdermal estradiol spray offers new treatment option for HRT

Transdermal estradiol spray offers new treatment option for HRT

Lenzetto (estradiol) is the first transdermal spray...

Drug shortages - live tracker

Drug shortages - live tracker

Added: Flutiform K-haler.
Use our constantly updated...